Startseite Crystal structure of {tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′}-(nitrito-κ2O,O′)nickel(II) perchlorate – ethanol (1/1), C26H27ClN8NiO7
Artikel Open Access

Crystal structure of {tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′}-(nitrito-κ2O,O′)nickel(II) perchlorate – ethanol (1/1), C26H27ClN8NiO7

  • Xin-Lun Li , Zhong-Ping Luo , Jun-Chao Zhang und Feng-Mei Nie EMAIL logo
Veröffentlicht/Copyright: 25. März 2020

Abstract

C26H27ClN8NiO7, triclinic, P1̄ (no. 2), a = 9.893(2) Å, b = 11.503(2) Å, c = 13.295(3) Å, α = 78.77(3)°, β = 70.52(3)°, γ = 83.40(3)°, V = 1397.0(6) Å3, Z = 2, Rgt(F) = 0.0423, wRref(F2) = 0.1032, T = 153.15 K.

CCDC no.: 1976381

The cationic complex, which is the main part of the title salt is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Green block
Size:0.23 × 0.21 × 0.16 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.85 mm−1
Diffractometer, scan mode:XTALAB, φ and ω
θmax, completeness:27.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:16933, 6358, 0.039
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 6056
N(param)refined:389
Programs:Olex2 [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Ni10.43233(3)0.14083(2)0.74578(2)0.02002(9)
Cl10.25409(6)−0.39307(5)1.00241(5)0.03244(14)
O10.50066(18)0.00607(14)0.65473(12)0.0302(3)
O20.35826(18)−0.04480(14)0.81061(13)0.0314(4)
O30.3721(3)−0.3376(2)0.91963(18)0.0672(7)
O40.25618(19)−0.37812(16)1.10737(14)0.0381(4)
O50.1256(3)−0.3367(3)0.9878(2)0.1014(12)
O60.2615(3)−0.5151(2)0.9962(2)0.0780(8)
O70.6033(2)−0.32853(16)0.67500(17)0.0458(5)
H0.5319−0.28020.68940.055*
N20.24016(18)0.19413(15)0.72507(14)0.0225(3)
N30.03104(18)0.29489(16)0.77405(14)0.0237(4)
H3−0.03820.34120.80960.028*
N10.36007(18)0.27940(15)0.85386(13)0.0213(3)
N40.53141(19)0.27803(16)0.63908(14)0.0232(4)
N50.5987(2)0.46313(17)0.60621(15)0.0281(4)
H50.60750.53440.61750.034*
N70.62793(19)0.12731(15)0.97679(14)0.0232(4)
H70.62150.15171.03700.028*
N60.57172(18)0.10429(15)0.83369(13)0.0218(3)
N80.4357(2)−0.07853(18)0.72414(16)0.0340(4)
C10.1619(2)0.17750(18)0.65931(16)0.0220(4)
C20.1973(2)0.1130(2)0.57457(17)0.0271(4)
H20.28770.07080.55200.032*
C30.0950(2)0.1134(2)0.52501(18)0.0322(5)
H3A0.11500.06920.46780.039*
C4−0.0380(3)0.1772(2)0.55656(19)0.0330(5)
H4−0.10520.17530.52000.040*
C5−0.0733(2)0.2426(2)0.63934(18)0.0295(5)
H5A−0.16270.28650.66030.035*
C60.0290(2)0.24072(19)0.69031(17)0.0238(4)
C70.1581(2)0.26406(18)0.79134(16)0.0222(4)
C80.2024(2)0.3019(2)0.87704(17)0.0254(4)
H8A0.17670.38750.87850.030*
H8B0.15120.25700.94880.030*
C90.4435(2)0.38625(19)0.79463(17)0.0265(4)
H9A0.37680.45750.79680.032*
H9B0.51220.39680.83140.032*
C100.5238(2)0.37549(19)0.67955(17)0.0242(4)
C110.6149(2)0.3037(2)0.53035(16)0.0246(4)
C120.6528(2)0.2349(2)0.44874(18)0.0286(5)
H120.62130.15680.46180.034*
C130.7386(2)0.2860(2)0.34737(18)0.0345(5)
H130.76550.24220.28940.041*
C140.7864(2)0.4006(3)0.32859(19)0.0377(6)
H140.84750.43150.25860.045*
C150.7476(3)0.4700(2)0.4086(2)0.0354(5)
H150.77960.54800.39530.043*
C160.6590(2)0.4197(2)0.50992(18)0.0277(5)
C170.3994(2)0.23089(18)0.95308(16)0.0230(4)
H17A0.32160.18311.00660.028*
H17B0.41410.29640.98610.028*
C180.5346(2)0.15523(17)0.92095(16)0.0200(4)
C190.6985(2)0.03809(18)0.83292(16)0.0214(4)
C200.7843(2)−0.0344(2)0.76110(18)0.0279(5)
H200.7589−0.04690.70130.033*
C210.9078(2)−0.0877(2)0.7801(2)0.0326(5)
H210.9687−0.13720.73200.039*
C220.9457(2)−0.0703(2)0.8690(2)0.0355(5)
H221.0323−0.10740.87890.043*
C230.8597(2)−0.0005(2)0.9420(2)0.0322(5)
H230.88410.01021.00280.039*
C240.7357(2)0.05330(19)0.92230(17)0.0234(4)
C250.6876(4)−0.3348(3)0.7436(3)0.0638(10)
HA0.6401−0.38260.81490.077*
HB0.6970−0.25400.75510.077*
C260.8322(3)−0.3899(3)0.6938(4)0.0834(14)
HC0.8750−0.34680.62040.125*
HD0.8234−0.47300.69060.125*
HE0.8936−0.38620.73760.125*

Source of material

Tris(2-benzimidazolylmethyl)amine (ntb) was synthesized according to the literature method [3]. An ethanol (10 mL) solution of ntb (0.080 g, 0.20 mmol) was added into an ethanol (20 mL) solution of Ni(ClO4)2 ⋅ 6H2O (0.074 g, 0.20 mmol) and sodium nitrite (0.014 g, 0.20 mmol), forming a clear green solution. The solution was stirred for one hour and then filtered. The filtrate was evaporated for three days to form green crystals.

Experimental details

The methyl groups were idealized and refined using rigid groups allowed to rotate about the N—C bond. The Uiso values of the hydrogen atoms of methyl groups were set to 1.5 Ueq(C) and the Uiso values of all other hydrogen atoms were set to 1.2 Ueq(C).

Comment

The nitrite anion is an ambidentate ligand which can form linkage isomers [4]. It can coordinate to metal ions in various ways. In the mononuclear complex, three coordination modes can often be observed, as unidentate N-(nitro) and O-(nitrito) coordination or as bidentate O,O-(nitrito) coordination [5]. It is known that the coordination mode of nitrite is mainly influenced by the steric hindrance imposed by the ancillary ligands. Tris(2-benzimidazolylmethyl)amine (ntb) is such a rigid tripodal tetradentate ligand [6], [7], [8]. In order to see how the ancillary ligand may influence the coordination mode of nitrite, a new complex [Ni(ntb)(NO2)]ClO4 ⋅ CH3CH2OH was prepared and characterized.

The title compound consists of a discrete [Ni(ntb)(NO2)]+ cation, a perchlorate anion and a non-coordinated solvent molecule of ethanol. In the complex cation, the nickel(II) ion is coordinated by four N atoms from ntb and two O atoms from nitrite, forming a distorted octahedral geometry (as shown in the figure, 50° displacement ellipsoids, hydrogen atoms omitted for clarity). The tertiary amine N1, two benzimidazole N2, N6, and the oxygen O1 atoms define the equatorial plane. Equatorial bond angles are in the range of 78.25(7)°–102.05(7)°, deviating from 90° remarkably [9]. Axial positions are occupied by O2 and N4 with a bond angle O2—Ni1—N4 of 158.66(7)°, showing a serious distorted octahedral environment. As expected, the tripodal ntb ligand coordinates to the nickel(II) ion with the three benzimidazole groups in a T shape. The plane of the nitrite is coplanar with one of them. The three Ni—Nbenzimidazole distances are from 2.005(2) Å to 2.0481(18) Å. The distance between Ni1 and tertiary amine N1 is 2.2498(18) Å, significantly longer than the Ni—Nbenzimidazole bond lengths, which is attributed to the steric requirement of the tripodal tetradentate ligand ntb [6], [7].

It is worth noting that the nitrite exhibits an asymmetrical bidentate chelating mode with two obvious different Ni—O bond lengths, Ni1—O1 [2.0663(17) Å], Ni1—O2 [2.2497(18) Å]. The same asymmetrical bidentate chelating mode was also observed in a ferrous complex [Fe(ntb)(κ2-O2N)]BF4 (2.104(4) Å and 2.338(4) Å for Fe1—O1 and Fe1—O2) [10]. But in [Cu(ntb)(NO2)]NO2, only mono-coordination of nitrite can be observed [a mixture of both κ1-NO2 and κ1-ONO linkage isomers] [11].

In the complex, two of the [Ni(ntb)NO2]+ cations are interlinked anti-symmetrically by hydrogen bonds to form a dimolecular unit. These dimolecular units are further interacted to form 1D chain structure by hydrogen bonds through the perchlorate anion and benzimidazole groups of ntb. The 1D chains are further expanded into 2D network structure by weak π–π stacking interactions.

Acknowledgements

This study was supported by Scientific Research Base Development Program of the Beijing Municipal Commission of Education (No. KM201910028013).

References

1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

2. Rigaku: CrystalClear-SM Expert. Rigaku Corporation, Tokyo, Japan (2011).Suche in Google Scholar

3. Thompson, L. K.; Ramaswamy, B. S.; Seymour, E. A.: Cobalt(II) and zinc(II) complexes of ‘tripod’ ligand tris(2-benzimidazolylmethyl)amine. some five-coordinated derivates and some with mixed stereochemistries. Can. J. Chem. 55 (1977) 878–888.10.1139/v77-122Suche in Google Scholar

4. Brayshaw, S. L.; Easun, T. L.; George, M. W.; Griffin, A. M. E.; Jhonson, A. L.; Raithby, P. R.; Savarese, T. L.; Schiffers, S.; Warren, J. E.; Warren, M. R.; Teat, S. J.: Photocrystallographic identification of metastable nitrito linkage isomers in a series of nickel(II) complexes. Dalton Trans. 41 (2012) 90–97.10.1039/C1DT11379HSuche in Google Scholar

5. Golchoubian, H.; Kocheksaraee, S. K.; Moayyedi, G.: Nitrite-bonded nickel(II) complex of N-cyclohexyl-N-(2-pyridinylmethyl)amine; synthesis, spectroscopic characterization, X-ray structure and DFT calculations. Polyhedron 123 (2017) 376–384.10.1016/j.poly.2016.12.014Suche in Google Scholar

6. Contreras, R.; Flores-Parra, A.; Migangos, E.; Téllez, F.; López-Sandoval, H.; Barba-Behrens, N.: From mono to polydentate azole and benzazole derivatives, versatile ligands for main group and transition metal atoms. Coord. Chem. Rev. 253 (2009) 1979–1999.10.1016/j.ccr.2009.02.020Suche in Google Scholar

7. Nie, F. M.; Chen, J.; Lu, F.: Synthesis, crystal structures and magnetic studies of terephthalato- and fumarato-bridged dinickel(II) complexes with tripodal poly-benzimidazole ligand. Inorg. Chim. Acta 365 (2011) 190–195.10.1016/j.ica.2010.09.009Suche in Google Scholar

8. Nie, F. M.; Li, Z.; Dong, Z. Y.; Yang, Y. L.: Crystal structure of (isonicotinato-O,O′)-[tris(2-benzimdazoly-N,N′, N′′-methyl)amine-N]nickel(II) perchlorate-methanol-water, [NiN(C24H21N6)(C6H4NO2)]ClO4 ⋅ CH3OH ⋅ H2O. Z. Kristallogr. NCS 224 (2009) 437–439.10.1524/ncrs.2009.0191Suche in Google Scholar

9. Chen, J.; Zhang, H.: Crystal structure of dinitrato-κO-bis(tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′)-(μ2-cyclohexane-1,4-dicarboxylato-κ4O,O′:O′′,O′′′)dimanganese(II) – methanol – water (1/6/2), C62H80Mn2N16O18. Z. Kristallogr. NCS 232 (2017) 775–777.10.1515/ncrs-2017-0029Suche in Google Scholar

10. Woollard-Shore, J. G.; Holland, J. P.; Jones, M. W.; Dilworth, J. R.: Nitrite reduction by copper complexes. Dalton Trans. 39 (2010) 1576–1585.10.1039/B913463HSuche in Google Scholar PubMed

11. Tsou, C. C.; Yang, W. L.; Liaw, W. F.: Nitrite activation to nitric oxide via one-fold protonation of iron(II)-O,O-nitrito complex: relevance to the nitrite reductase activity of deoxyhemoglobin and deoxyhemerythrin. J. Am. Chem. Soc. 135 (2013) 18758–18761.10.1021/ja4105864Suche in Google Scholar PubMed

Received: 2019-11-26
Accepted: 2020-01-09
Published Online: 2020-03-25
Published in Print: 2020-06-25

©2020 Xin-Lun Li et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of bis [1-(phenylsulfonyl)-2-(1-(pyrazin-2-yl)ethylidene)hydrazin-1-ido-κ3N,N′,O]cobalt(II), C24H22N8O4S2Co
  3. The crystal structure of 1,3-bis(4-(methoxycarbonyl)benzyl)-2-methyl-1H-benzo[d]imidazol-3-ium bromide, C26H25BrN2O4
  4. Crystal structure of {tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′}-(nitrito-κ2O,O′)nickel(II) perchlorate – ethanol (1/1), C26H27ClN8NiO7
  5. Crystal structure of catena-poly[aqua[(μ2-4,5-dicarboxylato-2-(2-carboxylatophenyl)imidazol-1-ido-κ4N,O,O′:N′)](μ2-4,4′-bipyridine-κ2N:N′)dicopper(II)], C22H14Cu2N4O7
  6. Crystal structure of chlorido-tris(4-methylbenzyl-κC)-(triphenylarsine oxide-κO)tin(IV), C42H42AsClOSn
  7. The crystal structure of 4,4′-bipyridinium bis(3-carboxy-2-nitrobenzoate) tetrahydrate, C13H13N2O8
  8. Crystal structure of 1-(3-chlorophenyl)-4-(4-(((2,3-dihydro-1H-inden-5-yl)oxy)methyl)phenethyl)piperazine, C28H31ClN2O
  9. Crystal structure of catena-poly[diaqua-bis(μ2-5,5′-(1H-imidazole-4,5-diyl)bis(tetrazol-2-ido)-κ4N,N′:N′′,N′′′)magnesium], C10H8N20O2Mg
  10. The crystal structure of (E)-2-((2-hydroxy-4-ethoxybenzylidene)amino)-2-methylpropane-1,3-diol monohydrate, C13H21NO5
  11. Crystal structure of catena-poly[diaqua-(μ2-bipyridine-κ2N:N′)-bis(3,5-dichloroisonicotinato-κO)cadmium(II)] dihydrate, C22H20CdCl4N4O8
  12. The crystal structure of 4-(4-chlorophenyl)cyclohexane-1-carboxylic acid, C13H15ClO2
  13. Redetermination of the crystal structure of yttrium(III) trinitrate(V) pentahydrate, Y(NO3)3 ⋅ 5 H2O, H10N3O14Y
  14. Crystal structure of catena-poly[di-μ2-chlorido-1,10-phenanthroline-κ2N,N′-cadmium(II)], C12H8Cl2CdN2
  15. Crystal structure of 4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)oxy)benzoic acid, C13H9F3N2O3
  16. Crystal structure of 3-acetyl-4-hydroxybenzoic acid, C18H16O8
  17. Crystal structure of bis(N,2-bis(4-ethoxybenzylidene)hydrazine-1-carbohydrazonothioato-κ2N,S)nickel(II) — N,N-dimethylformamide (1/2), C44H56N10S2O6Ni
  18. The crystal structure of 5-chloro-4,6-dimethoxypyrimidin-2-amine, C6H8ClN3O2
  19. Crystal structure of poly[aqua-(μ4-benzene-1,2,4,5-tetracarboxylato-κ4O,O′,O′′,O′′′)bis(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N)dinickel(II)], NiC17H14N5O5
  20. Crystal structure of poly[aqua(5-dimethylamino)naphthalene-1-sulfonato-κ2N:O)(μ2-4,4′-bipyridyl -κ2N:N′)silver(I)], C44H44Ag2N6O8S2
  21. Crystal structure of 1-[3-(trifluoromethyl)cinnamoyl]-3-(pyridin-2-yl-κN)pyrazole-κ2N-bis(2-phenylpyridinato-k2C,N)iridium(III) hexafluorophosphate complex, [C40H28F3IrN5O]PF6
  22. Crystal structure of catena-poly[aqua(μ6-piperazine-1,4-bisethanesulfonato-κ6N:N′:O:O′:O′′:O′′′)(μ2-pyrazinyl-κ2N:N′)disilver(I)sesquihydrate], C12H30Ag2N4O11S2
  23. Crystal structure of (E)-1-(2-nitrophenyl)-N-(o-tolyl)methanimine, C14H12N2O2
  24. Crystal structure of 4′-amino-3′,5′-diisopropyl-(1,1′-biphenyl)-4-carbonitrile, C19H22N2
  25. The crystal structure of poly[bis(N,N-dimethylformamide-κ1O)-tetrakis(μ2-cyanido-κ2C:N)dinickel(II)], C10H14N6O2Ni2
  26. Crystal structure of rac-trans-N,N′-bis(3-bromo-5-chlorosalicylidene)-1,2-cyclohexanediamine, C20H18Br2Cl2N2O2
  27. Crystal structure of rac-trans-N,N′-bis(3,5-dibromosalicylidene)-1,2-cyclohexanediamine, C20H18Br4N2O2
  28. The crystal structure of (dichromato-κ2O,O′)bis(1,10-phenanthroline-κ2N,N′)nickel(II), C12H16N4O7Cr2Ni
  29. The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridozincate(II) monohydrate, C10H18Cl4ZnN2O
  30. Crystal structure of bis(μ2-azido-k2N,N)-bis(2-amino-1-(N-(3-bromosalicylaldiminato))ethane)-dicopper(II), C20H18Br4N2O2
  31. Crystal structure of (η6-1-methyl-4-isopropylbenzene)-[5-bromo-2-(2-pyridyl)phenyl-κ2C,N]-chloro-ruthenium(II), C21H21BrClNRu
  32. Crystal structure of N-(methyl(oxo)(1-(6-(trifluoromethyl)pyridin-3-yl)ethyl)-λ6-sulfanylidene)cyanamide, C10H10F3N3OS
  33. Crystal structure of 6,6′-((cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-bromo-4-chlorophenolato-κ4N,N′,O,O′)nickel(II), C20H16Br2Cl2NiN2O2
  34. Redetermination of the crystal structure of catena-poly[aqua-(1,10-phenanthroline-κ2N,N′)-(μ2-tetraoxidomolybdato(VI)-κ2O:O′)manganese(II) monohydrate, C12H12N2O6MoMn
  35. The crystal structure tetrakis(μ2-o-chlorobenzoato-κ2O:O′)-bis(methanol-κ1O)dirhodium(II), C30H24Cl4O10Rh2
  36. Crystal structure of bis(2,3-diphenyltetrazolidine-5-thione-κ1S)-(nitrato-κ1O)-(nitrato-κ2O,O′)lead(II), C26H20N10O6S2Pb
  37. Crystal structure of bis(3-bromo-N-(1-(3-methylpyrazin-2-yl)ethylidene)benzohydrazonato-κ3O,N,N′)cadmium(II) hemihydrate, C28H25N8O2.5Br2Cd
  38. Crystal structure of catena-poly[tetrakis(μ2-trifluoroacetato-κ2O:O′)(μ2-2,5-dimethylpyrazine-κ2N,N′)dicopper(II)], C7H4CuF6NO4
  39. The crystal structure of catena-poly[bis[3-azoniapentane-1,5-diammonium][bis(μ4-oxo)-tetrakis(μ3-oxo)-heptakis(μ2-oxo)-tetradecaoxo-octa-molybdenum] dihydrate], (C8H36N6O29Mo8)n
  40. Crystal structure of tetraaqua-bis(2-((3,5,6-trichloropyridin-2-yl)oxy)acetato-κO)-nickel(II)—diaqua-bis(2-((3,5,6-trichloropyridin-2-yl)oxy)acetato-nickel(II), C28H24Cl12N4Ni2O18
  41. The crystal structure of bis(2-hydroxypyrimidinium) pentachloridobismuthate(III), (C4N2H5O)2BiCl5
  42. The crystal structure of catena-poly[(μ2-4,4′-dipyridine-κ2N,N′)-bis(3,5,6-trichloropyridine-2-oxyacetato-κO)-bis(ethanol-κO)nickel(II)], C28H26Cl6N4NiO8
  43. Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3,5-bis(4-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C26H20Cl3F2NO3S
  44. The crystal structure of 5-bromopicolinic acid monohydrate, C6H6BrNO3
  45. The crystal structure of 2-(3-(4-bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-8H-indeno[1,2-d]thiazole, C25H17BrFN3S
  46. The crystal structure of catena-poly[(μ2-2-((3-bromo-2-oxidobenzylidene)amino)acetato-κ4O,N,O′:O′′)-(dimethylformamide-κ1O)]zinc(II), C12H13N2O4BrZn
  47. Crystal structure of aqua-azido-κ1N-(6,6′-((propane-1,3-diylbis(azanylylidene))bis(methanylylidene))bis(3-bromophenolato)-κ4N,N′,O,O′iron(III), C17H16Br2FeN5O3
  48. The crystal structure of tris(1-ethylimidazole-κ1N)-(sulfato-κ2O,O′)vanadium(IV), C15H24N6O5SV
  49. Crystal structure of (E)-3-methoxy-N′-(1-(pyridin-2-yl)ethylidene)benzohydrazide, C15H15N3O2
  50. Crystal structure of dichloro-bis-(1-butyl-1H-benzo[d]imidazole)-nickel(II), C22H28Cl2N4Ni
  51. The crystal structure of 2-(2,3-dimethoxyphenyl)-3-hydroxy-4H-chromen-4-one, C17H14O5
  52. The crystal structure of 5-(2-(4-fluorophenyl)hydrazono)-4-methyl-2-((3-(5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene) hydrazono)-2,5-dihydrothiazole dimethylformamide monosolvate, C30H25FN10S⋅C3H7NO
  53. The crystal structure of 1,8-bis(pyridin-4-ylethynyl)anthracene-1,2,4,5-tetrafluoro-3,6-diiodobenzene (2/1), C62H32F4I2N4
  54. The crystal structure of 3,6-di-tert-butyl-1,8-diiodo-9-methyl-9H-carbazole, C21H25I2N
  55. The crystal structure of 8-((4-chlorophenylamino)methylene)-6,10-dioxaspiro[4.5]decane-7,9-dione, C15H14ClNO4
  56. The crystal structure of catena-poly[oktaaqua-bis(μ2-4,4′-ethene-1,2-diyldipyridine-κ2N:N′)-(μ2-3,3′-(1-oxidodiazene-1,2-diyl)diphthalato-κ2O:O′)dicobalt(II)] dihydrate, C28H36N4O19Co2
  57. Crystal structure of (E)-1-(2-cyano-3-oxo-1-phenylprop-1-en-1-yl)-3,7-diphenylindolizine-6-carbonitrile, C31H19N3O
  58. Crystal structure of 1,1′-bis(diphenylphosphino)ferrocene-(1,1′-bis(diphenylphosphino)ferrocene-κ2P,P′)-(O-isobutyl sulfurodithioito-κ2S,S′)copper(I), C39H37CuFeOP2S2
  59. Crystal structure of poly[(5-bimethylamino-1-naphthalenesulfonato-κO)-(μ3-hexamethylenetetramino-κ3N:N′:N′′)silver(I)] dihydrate, C36H52Ag2N10O8S2
  60. Crystal structure of poly[μ2-diaqua-(μ2-2-amino-4,5-dicyano-κ2N:N′-imidazol-1-ide)sodium(I)], C5H6N5O2Na
  61. Crystal structure of (1,3-propanediamine-κ2N,N′)(N-(3-aminopropyl)-α-methyl aspartato-κ4N,N′,O,O′)cobalt(III) chloride, C11H24ClCoN4O4
  62. Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one-dichloromethane (1/1), C26H20Cl2F3NO3S
  63. Crystal structure of (S)-(+)-1-cyclohexylethylaminium chloride, C8H18NCl
  64. The crystal structure of tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(o-pyridyl)imidazoline-1-oxyl 3-oxide-κ2N,O)yttrium(III), C24H32N9O13Y
  65. Hydrogen bonding versus packing effects in the crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetraiodidozincate(II), C10H16I4ZnN2
  66. Dimerization of 2-[(2-((2-aminophenyl)thio)phenyl)amino]-cyclohepta-2,4,6-trien-1-one through hydrogen bonding, C19H16N2OS
  67. Crystal structure of 1-(4-chloro-phenyl)-7-ethoxyl-6,8-difluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, C18H12ClF2NO4
  68. Crystal structure of 7-ethoxy-6,8-difluoro-4-oxo-1-pyridin-2-ylmethyl-1,4-dihydro-quinoline-3-carboxylic acid, C18H14F2N2O4
  69. Crystal structure of octahydro-7aR,8′R-dimethylspiro[isobenzofuran-4(1H), 4′ (3′H)-[1H-7,9a]methanocyclohepta[c]pyran]-1′,3, 9′ (3aH,4′aH)-trione, C20H26O5
  70. Crystal structure of bis(5-ethoxy-2-(((1-hydroxy-2-methyl-3-oxidopropan-2-yl)imino)methyl)phenolato-κ3N,O,O’)manganese(IV) – methanol (1/1), C27H38MnN2O9
  71. Crystal structure of 8a,8a′′-oxybis(8aH-8,9-dioxa-3a1λ4-aza-8aλ4-borabenzo[fg]tetracene), C34H22B2N2O5
  72. Crystal structure of bromido-triphenyl-(triphenylarsine oxide-κO)tin(IV), C36H30AsBrOSn
  73. Crystal structure of catena-poly[chlorido-(μ2-formato-κ2O:O′)-(1,10-phenathroline-κ2N,N′)copper(II)], C26H18Cl2Cu2N4O4
  74. The crystal structure of poly[(μ10-5-carboxyisophthalato-κ10O)disodium], C9H4Na2O6
  75. The crystal structure of 3,5-difluoroisonicotinic acid, C6H3F2NO2
  76. The crystal structure of ethyl-1-(N-(adamantan-1-yl)-carbamothioyl)piperidine-4-carboxylate, C19H30N2O2S
  77. Crystal structure of 5-methyl-3-phenyl-1-tosyl-1,2,3,4-tetrahydropyridine, C19H21NO2S
  78. Crystal structure of bis((3-chlorosalicylidene)-ethylenediaminato-κ4N,N′,O,O′)nickel (II), C16H12Cl2NiN2O2
  79. Crystal structure of (E)-N′-(2-chloro-6-hydroxybenzylidene)-4-hydroxybenzohydrazide — dihydrofuran-2(3H)-one (1/1), C18H17ClN2O5
  80. Crystal structure of bis((3-bromosalicylidene)-ethylenediaminato-κ4N,N′,O,O′) nickel (II), C16H12Br2NiN2O2
  81. Crystal structure of trimethylsulfoxonium tetrachloridocobaltate(II) [(CH3)3SO]2CoCl4
Heruntergeladen am 29.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0862/html
Button zum nach oben scrollen